USPTO Examiner TOWA RENE T - Art Unit 3791

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
19252895SYSTEM AND A METHOD OF DETERMINING A PHYSIOLOGICAL PARAMETER OF A BODY COMPRISING BLOOD PERFUSED TISSUEJune 2025February 2026Allow710YesNo
19172140ROTATING FINE NEEDLE CORE BIOPSY DEVICE WITH IMPROVED CAMMING SUBASSEMBLYApril 2025October 2025Allow620YesNo
18654877Wearable Device And Method For Non-Invasive Assessment Of Glymphatic FlowMay 2024November 2025Allow1910YesNo
18636234Non-Invasive Assessment Of Glymphatic Flow And Neurodegeneration From A Wearable DeviceApril 2024October 2025Allow1820YesNo
18581296Biopsy Needle Set With Reduced Deflection and Improved TargetingFebruary 2024October 2025Allow2030YesNo
18510580SYSTEMS AND METHODS FOR IMPROVING WORKPLACE SAFETYNovember 2023August 2025Abandon2110NoNo
18387465Calibration of an Inertial Measurement Unit for Improving the Accuracy of a Biomechanical SkeletonNovember 2023November 2025Allow2410NoNo
18451100Non-Invasive Assessment Of Glymphatic Flow And Neurodegeneration From A Wearable DeviceAugust 2023May 2024Abandon910NoNo
18348984SYSTEMS AND METHOD FOR SKIN ANALYSIS USING ELECTRONIC DEVICESJuly 2023November 2024Allow1720NoNo
18130606SENSOR ENABLED WOUND THERAPY DRESSINGS AND SYSTEMS IMPLEMENTING CYBERSECURITYApril 2023August 2024Allow1610NoNo
18295093Methods of Treating Deep and Early-Stage Pressure Induced Tissue DamageApril 2023May 2024Allow1410NoNo
18185365Wearable Device And Method For Non-Invasive Assessment Of Glymphatic FlowMarch 2023April 2024Allow1320YesNo
18178760SYSTEM AND METHOD OF TAKING AND COLLECTING TISSUE CORES FOR TREATMENTMarch 2023August 2025Allow2920YesNo
18099329CYTOLOGY SAMPLING SYSTEM AND METHOD OF UTILIZING THE SAMEJanuary 2023April 2024Allow1510NoNo
18155627SYSTEMS AND METHODS FOR MONITORING WORKPLACE ACTIVITIESJanuary 2023August 2024Abandon1910NoNo
18047871SYSTEM FOR COLOR-CODING MEDICAL INSTRUMENTATION AND METHODS OF USEOctober 2022April 2023Allow600NoNo
17937952Non-Invasive Assessment Of Glymphatic Flow And Neurodegeneration From A Wearable DeviceOctober 2022July 2023Allow920YesNo
17934982CONTROL UNIT FOR MONITORING PATIENT COMPLIANCE WITH A COMPRESSION THERAPY REGIMENSeptember 2022December 2024Allow2740YesYes
17947512THERMOGRAPHIC DEVICE FOR MEASUREMENT OF DIFFERENTIAL TEMPERATURES IN TISSUESeptember 2022March 2024Allow1820NoNo
17797017METHOD FOR COLLECTING SPECIMEN FROM GASTROINTESTINAL MUCOSAAugust 2022January 2026Abandon4110NoNo
17794863BONE MARROW ASPIRATION AND BIOPSY DEVICEJuly 2022March 2026Abandon4410NoNo
17852633BIOPSY DEVICE WITH APPLIED IMAGINGJune 2022November 2024Allow2940YesNo
17848490POSITION DETECTION BASED ON TISSUE DISCRIMINATIONJune 2022March 2023Allow910NoNo
17840488LARGE SURFACE AREA TEMPERATURE SENSING DEVICEJune 2022September 2023Allow1520NoNo
17834114SYSTEMS AND TECHNIQUES FOR ESTIMATING THE SEVERITY OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN A PATIENTJune 2022February 2026Allow4420YesNo
17831675METHOD AND APPARATUS FOR MEASURING THE PROSTATIC URETHRAL LENGTHJune 2022December 2025Abandon4301NoNo
17832188APPARATUS FOR OBTAINING BIOLOGICAL INFORMATIONJune 2022January 2023Allow700NoNo
17750531POWER-ADAPTABLE DEVICE FOR SCANNING A HUMAN INTRA-CAVITYMay 2022October 2025Abandon4160YesYes
17773794BIOPSY APPARATUS HAVING A PIERCING MODULEMay 2022October 2025Allow4210YesNo
17710401SYRINGE-BASED FLUID DIVERSION MECHANISM FOR BODILY FLUID SAMPLINGMarch 2022December 2022Allow910NoNo
17693756SYSTEMS AND METHODS FOR PROVIDING SENSORY FEEDBACK DURING EXERCISEMarch 2022August 2025Abandon4110NoNo
17690977MACHINE LEARNING PLATFORM AND SYSTEM FOR DATA ANALYSISMarch 2022February 2024Allow2331YesNo
17675299BIOPSY DEVICEFebruary 2022June 2025Allow4001NoNo
17591139METHODS OF TREATING DEEP AND EARLY-STAGE PRESSURE INDUCED TISSUE DAMAGEFebruary 2022March 2023Allow1330YesNo
17579957Systems and Methods for Performing Neurophysiologic Monitoring During Spine SurgeryJanuary 2022May 2025Abandon4040YesNo
17645940COMPRESSIBLE HEART VALVE ANNULUS SIZING TEMPLATESDecember 2021December 2022Allow1100NoNo
17532379URINE COLLECTION DEVICENovember 2021May 2023Abandon1710NoNo
17499823DEVICE AND METHOD FOR THREE-DIMENSIONALLY MAPPING ACUPUNCTURE POINTSOctober 2021August 2025Abandon4610NoNo
17492756SEALANT PLUG DELIVERY SYSTEM AND METHOD OF USEOctober 2021May 2025Allow4410NoNo
17483272HEART RATE AND BLOOD OXYGEN MONITORING DEVICESeptember 2021October 2024Allow3700NoNo
17466477GUIDE WIRESeptember 2021July 2025Allow4711NoNo
17462468MUSCLE FATIGUE EVALUATION METHOD AND MUSCLE FATIGUE EVALUATION SYSTEMAugust 2021March 2025Abandon4310NoNo
17459656METHOD AND APPARATUS FOR INDICATING THE EMERGENCE OF AN ULCERAugust 2021February 2023Allow1810NoNo
17389288ASSESSING PROGRESSION OF HUNTINGTON'S DISEASEJuly 2021June 2025Abandon4720NoNo
17352052SYSTEM AND METHOD FOR CONTROLLING A VALVE OF A PORTABLE MEDICAL DEVICEJune 2021March 2024Allow3330YesNo
17304148SYSTEMS, DEVICES AND METHODS FOR TISSUE REMOVAL AND ANALYSISJune 2021July 2024Abandon3710NoNo
17307051SKIN TREATMENT APPLICATORMay 2021April 2023Allow2340YesNo
17307032SKIN TREATMENTMay 2021September 2025Allow5270YesNo
17288134METHODS, DEVICES, AND SYSTEMS FOR PHYSIOLOGICAL PARAMETER ANALYSISApril 2021October 2024Allow4220YesNo
17239193SYSTEM AND METHOD FOR COORDINATED LASER DELIVERY AND IMAGINGApril 2021May 2024Abandon3730NoNo
17287805INDUCTOR-CAPACITOR BASED SENSOR APPARATUSESApril 2021March 2026Abandon5940NoNo
17286105ON-BODY COMMUNICATION SYSTEM AND METHOD OF COMMISSIONING THE SAMEApril 2021September 2024Abandon4110NoNo
17229079SEALANT PLUG DELIVERY SYSTEM AND METHOD OF USEApril 2021June 2021Allow300NoNo
17283406DEVICES, SYSTEMS AND METHODS FOR TISSUE DETECTION, POSITION DETERMINATION AND TISSUE ABLATIONApril 2021October 2023Abandon3020NoNo
17280375A POWER-ADAPTABLE DEVICE FOR SCANNING A HUMAN INTRA-CAVITYMarch 2021May 2024Abandon3730YesNo
17200788METHOD AND SYSTEM FOR IN-VIVO, AND NON-INVASIVE MEASUREMENT OF METABOLITE LEVELSMarch 2021September 2021Allow610NoNo
17192161PHYSICAL ACTIVITY AND WORKOUT MONITORMarch 2021February 2022Allow1130YesNo
17190996MICROFORCEPSMarch 2021December 2025Abandon5770NoNo
17170291SYSTEMS AND METHODS FOR IMPROVING WORKPLACE SAFETYFebruary 2021October 2023Abandon3320YesNo
17156950BIOPSY TOOL HAVING PRE-APPLIED VACUUM FORCEJanuary 2021April 2025Abandon5130YesNo
17259286DEVICE, SYSTEM AND METHOD FOR DETERMINING A STRESS LEVEL OF A USERJanuary 2021June 2025Abandon5330YesNo
17142041SAMPLING ASSEMBLYJanuary 2021May 2025Abandon5360YesNo
17125320MEDICAL INSTRUMENT WITH SHAFT ACTUATING HANDLE CONFIGURED TO ACCEPT STYLETDecember 2020July 2024Abandon4320YesNo
17102491BIOPSY NEEDLE ASSEMBLY AND METHODNovember 2020December 2024Abandon4930NoNo
17096985DIAGNOSTIC MEASUREMENT DEVICES AND METHODSNovember 2020March 2023Abandon2810NoNo
17089461SKIN BIOPSY DEVICENovember 2020July 2023Allow3210NoNo
17089632TISSUE ACQUISITION HELIX DEVICENovember 2020May 2024Allow4220NoNo
17086113SYSTEMS AND METHODS FOR DIAGNOSIS AND TREATMENT OF SWALLOWING DISORDERS WITH GAMIFICATIONOctober 2020September 2024Allow4740YesNo
17082387Biopsy System with a Core Collector that Remains Radially Centered in an Outer Cannula While Severing a Tissue SampleOctober 2020December 2023Allow3820YesNo
16949401NEEDLE BIOPSY DEVICEOctober 2020August 2023Abandon3420NoNo
17069422MEDICAL DEVICE FOR CONCURRENT COLLECTION OF MULTIPLE TISSUE SAMPLESOctober 2020June 2024Allow4430YesNo
17065977Instrument Handle for Use with Instrument Alignment Feedback System and MethodOctober 2020September 2025Allow5930YesNo
17041046FOLLICULAR CONTENT STORAGESeptember 2020February 2024Abandon4110NoNo
17016529Rotary Oblique-Cutting Biopsy NeedleSeptember 2020June 2023Abandon3420NoNo
17001796High Sensitivity Movement Disorder Treatment Device or SystemAugust 2020September 2022Allow2510NoNo
16968540NEEDLE TIPS, NEEDLES FOR TISSUE COLLECTION, METHODS OF FABRICATION, AND METHODS OF USEAugust 2020December 2022Abandon2810NoNo
16902579Device for Biological Cell Collection and Method of UseJune 2020November 2024Allow5370YesNo
16866274Shape Sensing Biopsy NeedleMay 2020September 2023Allow4010NoNo
16854287UNIT FOR COLLECTING BLOODApril 2020May 2024Abandon4950NoNo
16853016DEVICES AND METHODS FOR OBTAINING ADENOMYOSIS AND OTHER BIOPSY SAMPLESApril 2020July 2023Allow3820NoNo
16849538MEDICAL TESTING APPARATUS AND METHOD OF USEApril 2020April 2024Allow4850YesYes
16645779SENSOR ENABLED WOUND THERAPY DRESSINGS AND SYSTEMS IMPLEMENTING CYBERSECURITYMarch 2020February 2023Allow3510NoNo
16810997CYTOLOGY SAMPLING SYSTEM AND METHOD OF UTILIZING THE SAMEMarch 2020September 2022Allow3100NoNo
16644291Steerable Catheter with Portions of Different StiffnessMarch 2020July 2023Abandon4020NoNo
16789617MARKER DELIVERY DEVICE WITH STERILE GUIDEFebruary 2020March 2024Allow4940YesNo
16633888MAGNETIC ROBOTJanuary 2020January 2023Allow3510NoNo
16630062SYSTEM FOR MEASURING THE ELECTRICAL IMPEDANCE IN HUMAN TISSUESJanuary 2020August 2023Abandon4340YesNo
16731025VIDEO-BASED FALL RISK ASSESSMENT SYSTEMDecember 2019April 2025Abandon6060YesNo
16618362SENSOR APPLICATOR ASSEMBLY FOR CONTINUOUS GLUCOSE MONITORING SYSTEMDecember 2019September 2021Allow2220NoNo
16616220CORE-WIRE JOINT WITH MICRO-FABRICATED MEDICAL DEVICESNovember 2019November 2025Abandon6060YesNo
16611477DEVICES AND METHODS FOR COLLECTING GASTROINTESTINAL SAMPLESNovember 2019May 2023Allow4240YesNo
16670047DEVICE AND PROCESS FOR ELECTRICAL IMPEDANCE TOMOGRAPHY (EIT) WITH IDENTIFICATION OF A HEART REGIONOctober 2019September 2024Abandon5960YesNo
16591802SYSTEM AND METHOD OF DETECTING SLEEP DISORDERSOctober 2019February 2023Allow4120NoNo
16495933Sensing System for Pericardial AccessSeptember 2019July 2022Abandon3440NoYes
16571226Method for measuring exerciseSeptember 2019August 2022Allow3510NoNo
16493584VARIABLE STIFFNESS NEEDLESeptember 2019July 2023Abandon4660YesNo
16493043AIRWAY SIZING APPARATUSSeptember 2019March 2023Abandon4220NoNo
16486299JAW ASSEMBLY FOR SURGICAL TOOL AND BIOPSY SAMPLE COLLECTION MEMBERAugust 2019July 2024Abandon5930YesNo
16483951POSITION DETECTION BASED ON TISSUE DISCRIMINATIONAugust 2019March 2022Allow3120YesYes
16530925Systems and Methods for Performing Neurophysiologic MonitoringAugust 2019August 2022Allow3610YesNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner TOWA, RENE T.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
21
Examiner Affirmed
13
(61.9%)
Examiner Reversed
8
(38.1%)
Reversal Percentile
59.8%
Higher than average

What This Means

With a 38.1% reversal rate, the PTAB reverses the examiner's rejections in a meaningful percentage of cases. This reversal rate is above the USPTO average, indicating that appeals have better success here than typical.

Strategic Value of Filing an Appeal

Total Appeal Filings
51
Allowed After Appeal Filing
13
(25.5%)
Not Allowed After Appeal Filing
38
(74.5%)
Filing Benefit Percentile
37.0%
Lower than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 25.5% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is below the USPTO average, suggesting that filing an appeal has limited effectiveness in prompting favorable reconsideration.

Strategic Recommendations

Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.

Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.

Examiner TOWA, RENE T - Prosecution Strategy Guide

Executive Summary

Examiner TOWA, RENE T works in Art Unit 3791 and has examined 272 patent applications in our dataset. With an allowance rate of 62.1%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 44 months.

Allowance Patterns

Examiner TOWA, RENE T's allowance rate of 62.1% places them in the 22% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.

Office Action Patterns

On average, applications examined by TOWA, RENE T receive 3.48 office actions before reaching final disposition. This places the examiner in the 94% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by TOWA, RENE T is 44 months. This places the examiner in the 15% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.

Interview Effectiveness

Conducting an examiner interview provides a +1.4% benefit to allowance rate for applications examined by TOWA, RENE T. This interview benefit is in the 20% percentile among all examiners. Note: Interviews show limited statistical benefit with this examiner compared to others, though they may still be valuable for clarifying issues.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 14.0% of applications are subsequently allowed. This success rate is in the 9% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 16.6% of cases where such amendments are filed. This entry rate is in the 18% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 59.3% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 50% percentile among all examiners. Note: Pre-appeal conferences show below-average success with this examiner. Consider whether your arguments are strong enough to warrant a PAC request.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 55.3% of appeals filed. This is in the 27% percentile among all examiners. Of these withdrawals, 53.8% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows below-average willingness to reconsider rejections during appeals. Be prepared to fully prosecute appeals if filed.

Petition Practice

When applicants file petitions regarding this examiner's actions, 58.8% are granted (fully or in part). This grant rate is in the 62% percentile among all examiners. Strategic Note: Petitions show above-average success regarding this examiner's actions. Petitionable matters include restriction requirements (MPEP § 1002.02(c)(2)) and various procedural issues.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 4.0% of allowed cases (in the 83% percentile). Per MPEP § 1302.04, examiner's amendments are used to place applications in condition for allowance when only minor changes are needed. This examiner frequently uses this tool compared to other examiners, indicating a cooperative approach to getting applications allowed. Strategic Insight: If you are close to allowance but minor claim amendments are needed, this examiner may be willing to make an examiner's amendment rather than requiring another round of prosecution.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 50% percentile). This examiner issues Quayle actions less often than average. Allowances may come directly without a separate action for formal matters.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Prepare for rigorous examination: With a below-average allowance rate, ensure your application has strong written description and enablement support. Consider filing a continuation if you need to add new matter.
  • Expect multiple rounds of prosecution: This examiner issues more office actions than average. Address potential issues proactively in your initial response and consider requesting an interview early in prosecution.
  • Plan for RCE after final rejection: This examiner rarely enters after-final amendments. Budget for an RCE in your prosecution strategy if you receive a final rejection.
  • Plan for extended prosecution: Applications take longer than average with this examiner. Factor this into your continuation strategy and client communications.
  • Examiner cooperation: This examiner frequently makes examiner's amendments to place applications in condition for allowance. If you are close to allowance, the examiner may help finalize the claims.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.